Mayo Clinic Laboratory and pathology research roundup: May 16
Share this:
The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.
Featured Abstract
Development and validation of an acute respiratory distress syndrome prediction model in Coronavirus Disease 2019: Updated lung injury prediction score.
To develop and validate an updated lung injury prediction score for coronavirus disease 2019 (COVID-19) (c-LIPS) tailored for predicting acute respiratory distress syndrome (ARDS) in COVID-19.
Published to PubMed This Week
- The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms.
British journal of haematology - Hereditary gelsolin amyloidosis: A rare cause of cranial, peripheral and autonomic neuropathies linked to D187N and Y447H substitutions.
Amyloid - Detection of endometrial cancer using tampon-based collection and methylated DNA markers.
Gynecologic Oncology - Perianal Treponema pallidum.
Mayo Clinic Proceedings - Heart failure with preserved ejection fraction: JACC scientific statement.
Journal of the American College of Cardiology - Immune checkpoint inhibitor associated central nervous system autoimmunity.
European Journal of Neurology - Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): A global, randomised, placebo-controlled, phase 3 study.
The Lancet. Oncology - Clinical manifestations, treatment and outcomes of patients infected with Mycobacterium haemophilum with a focus on immune reconstitution inflammatory syndrome: A retrospective multi-site study.
Infectious disease (London, England) - Relationship among three common hematological premalignant conditions.
Leukemia
